Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NECL-1 ELISA Kit (AC3720)
Cat.#: ASET-2309
Specifications
Description Human NECL-1 ELISA Kit allows for the in vitro quantitative determination of human NECL-1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2001 Human BCS1L ELISA Kit (AC3412) Quantitative inquiry ASET-2409 Mouse Ornithine Aminotransferase ELISA Kit (AC3820) Quantitative inquiry ASET-2170 Rat Dopamine Receptor D1 ELISA Kit (AC3581) Quantitative inquiry ASET-2312 Human Pannexin 1 ELISA Kit (AC3723) Quantitative inquiry ASET-1513 Human APLNR ELISA Kit (AC2924) Quantitative inquiry ASET-1034 Rat LIF ELISA Kit (AC2445) Quantitative inquiry ASET-1358 Human Cannabinoid Receptor II ELISA Kit (AC2769) Quantitative inquiry ASET-1434 Rat Rabphilin 3A ELISA Kit (AC2845) Quantitative inquiry ASET-2484 Mouse Nrg4 ELISA Kit (AC3895) Quantitative inquiry ASET-1628 Human HAS3 ELISA Kit (AC3039) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket